Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 52 | Longs Won 17/49 34% | Profit Factor 1.84 |
| Profitability | Shorts Won 3/3 100% | Standard Deviation $6,413.23 |
| Average Win $6,122.34 | Best Trade (Aug 23) $29,622.33 | Sharpe Ratio -59.71 |
| Average Loss -$2,078.83 | Worst Trade (Jan 02) -$13,623.82 | Z-Score -3.29 (100%) |
| Commissions $0 | Avg. Trade Length 1m 3w 3d | Expectancy $1,075.47 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | 0.01% | 0.07% | 0.39% | 1.69% | 5.8% | 16.83% | 43.11% |
| Consecutive Losing Trades | 75 | 68 | 60 | 53 | 45 | 38 | 30 | 23 | 15 | 8 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences Inc. | 1,022.05 | $160,517.57 | $155,924.22 | - | -$4,593.35 | -2.86% | -0.242% |